Does CJC-1295 (GHRH) New Zealand Raise Heart Attack Risk Levels?
One such compound that has gained significant attention from scientists researching peptides for muscle enhancement is CJC-1295, a synthetic growth hormone-releasing hormone (GHRH). However, with the increasing use of such peptides, concerns about their safety, particularly their impact on heart health, have arisen.
CJC-1295 DAC (GHRH) New Zealand
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) that stimulates the release of growth hormone (GH) from the pituitary gland. It is often used in conjunction with other peptides to enhance muscle growth, fat loss, and recovery.
CJC-1295 DAC (GHRH) works by binding to GHRH receptors in the pituitary gland, leading to an increase in GH release. This, in turn, stimulates the production of insulin-like growth factor 1 (IGF-1), which plays a crucial role in muscle growth and repair.
CJC-1295 is available with or without DAC – the Drug affinity complex. Additional information on the drug affinity complex discover our blog.
Potential Benefits of CJC-1295 (GHRH) New Zealand
Enhanced Muscle Growth
By increasing GH and IGF-1 levels, CJC-1295 DAC (GHRH) can potentially accelerate muscle protein synthesis, leading to greater muscle mass gains in healthy adults.
Improved Fat Loss
Higher GH levels are associated with improved lipolysis (fat breakdown), making CJC-1295 DAC peptide a popular choice for those aiming to reduce body fat while maintaining or increasing muscle mass.
Accelerated Recovery
The pulsatile release of human growth hormone aids in recovery by promoting tissue repair and reducing inflammation, which can lead to faster healing times and reduced soreness after intense workouts.
Growth Hormone Deficiency
CJC-1295 DAC (GHRH) could potentially offer a solution to those with GH deficiency, because of the stimulation of growth hormone secretion.
Cardiovascular Concerns: Can CJC-1295 DAC (GHRH) Cause a Heart Attack?
The Link Between GH and Heart Health
Growth hormone plays a complex role in cardiovascular health. While it is essential for normal heart function and muscle mass maintenance, excessive levels can have adverse effects.
Elevated growth hormone levels can lead to increased heart size (cardiac hypertrophy), which may predispose individuals to cardiovascular issues.
Research and Evidence
Currently, there is limited direct evidence linking CJC-1295 DAC (GHRH) injections specifically to heart attacks. Most of the current New Zealand research focuses on GH and its analogues’ general effects on cardiovascular health.
However, anecdotal reports and theoretical concerns necessitate caution, especially for individuals or research subjects with pre-existing heart conditions.
Factors That May Increase Risk
- Dosage and Duration: Higher doses and prolonged use of CJC-1295 may increase the risk of adverse cardiovascular effects.
- Genetic Predisposition: Individuals with a family history of heart disease may be more susceptible to potential risks.
- Pre-existing Conditions: Those with existing heart conditions should exercise extreme caution and consult a healthcare professional before using CJC-1295.
Which Peptides Promote Heart Health?
Peptides like BPC-157 have shown promising potential in promoting cardiovascular health by supporting tissue repair, reducing inflammation, and enhancing blood vessel function.
The newly discovered peptide Tesofensine, a novel compound with dual action as a serotonin-norepinephrine-dopamine reuptake inhibitor, may aid in weight management which can indirectly benefit cardiovascular health by reducing risk factors like obesity.
Furthermore, clinical research has found that Human C peptides, derived from proinsulin, have been studied for their role in improving insulin sensitivity and glucose metabolism, which are crucial factors in maintaining cardiovascular wellness by managing blood sugar levels and reducing the risk of diabetes-related complications.
Incorporating these peptides into a comprehensive approach to cardiovascular health may offer multifaceted benefits in maintaining heart function and overall well-being.
Conclusion
While CJC-1295 (GHRH) holds promise for enhancing muscle growth, fat loss, and recovery, its potential impact on heart health cannot be ignored. Although direct evidence linking the peptide to heart attacks is limited, the theoretical risks warrant a cautious approach. Fitness enthusiasts and bodybuilders should prioritise their heart health by consulting healthcare professionals. By taking these precautions and with further research, you can make an informed decision about whether CJC-1295 DAC (GHRH) aligns with the aim of your peptide research. Read about the differences between CJC-1295 DAC and CJC-1295 No Dac peptides here.
The efficacy of many synthetic peptide hormone as therapeutic agent are still under investigation. The side effects on the human body are still the subject of research studies, therefore many are not yet approved for human consumption. PharmaGrade.Store supplies high purity peptides online New Zealand for research purposes only.
References:
[1] Alba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, Salvatori R. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1290-4.
[2] Frutos MG, Cacicedo L, Fernández C, Vicent D, Velasco B, Zapatero H, Sánchez-Franco F. Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis. Am J Physiol Endocrinol Metab. 2007 Nov;293(5):E1140-52.
ALL PRODUCT INFORMATION AND ARTICLES ON THIS SITE ARE FOR EDUCATIONAL PURPOSES ONLY
DISCLAIMER: All products sold by PharmaGrade.Store are for research and laboratory use only. These products are not designed for use or consumption by humans or animals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such. By purchasing from our Website the buyer accepts and acknowledges the risks involved with handling of these products. All articles and product information provided on this Website are for informational and educational purposes only. Handling and use of these products should be restricted to suitably qualified professionals.
-
Sale!
CJC-1295 DAC Nasal Spray
£33.16 – £61.32 Select options This product has multiple variants. The options may be chosen on the product page -
PRICE REDUCTION
PRICE REDUCTION
PRICE REDUCTION
PRICE REDUCTION
PRICE REDUCTION
Ipamorelin & CJC No-DAC Blend Nasal Spray
£33.71 – £112.36 Select options This product has multiple variants. The options may be chosen on the product page -
Sale!
HGH Frag 176-191 & CJC 1295 Blend Nasal Spray
£38.48 – £71.96 Select options This product has multiple variants. The options may be chosen on the product page -
SALE
CJC1295 & GHRP-6 Blend Nasal Spray
£22.62 – £40.99 Select options This product has multiple variants. The options may be chosen on the product page